Trial intelligence / Profile preview

Donepezil for prevention of post-operative delirium after elective hip or knee replacement in adults aged 65 years or older

ISRCTN55655483Phase 3Terminated

Sponsor
Imperial College London
Start
Mar 2008
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial of donepezil in postoperative delirium (POD), sponsored by Imperial College London. Started Mar 2008; status: terminated.

02

Drugs

donepezil
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ISRCTN55655483.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN55655483.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call